ProfileGDS4718 / 227767_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 95% 89% 91% 95% 89% 93% 93% 94% 94% 95% 94% 92% 86% 92% 93% 94% 87% 91% 79% 92% 93% 95% 94% 95% 89% 93% 90% 94% 91% 92% 92% 95% 95% 94% 94% 93% 93% 95% 89% 95% 92% 87% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.8603793
GSM549102patient 115, normal, homogenized [OPG study]10.195295
GSM549104patient 119, normal, homogenized [OPG study]9.124989
GSM549108patient 138, normal, homogenized [OPG study]9.3523691
GSM549119patient 077, normal, homogenized [OPG study]10.284995
GSM549133patient 032, cancer, homogenized [OPG study]9.1021889
GSM549139patient 042, cancer, homogenized [OPG study]9.7795793
GSM549099patient 107, normal, homogenized [OPG study]9.6236393
GSM549109patient 139, normal, homogenized [OPG study]9.9630794
GSM549110patient 046, normal, homogenized [OPG study]10.10594
GSM549114patient 063, normal, homogenized [OPG study]10.356795
GSM549122patient 082, normal, homogenized [OPG study]10.008794
GSM549134patient 033, cancer, homogenized [OPG study]9.5445692
GSM549136patient 036, cancer, homogenized [OPG study]8.6537286
GSM549140patient 044, cancer, homogenized [OPG study]9.5780492
GSM549111patient 047, normal, homogenized [OPG study]9.9510493
GSM549113patient 057, normal, homogenized [OPG study]10.217694
GSM549132patient 031, cancer, homogenized [OPG study]8.7584587
GSM549137patient 038, cancer, homogenized [OPG study]9.247391
GSM549142patient 047, cancer, homogenized [OPG study]7.5414579
GSM549100patient 110, normal, homogenized [OPG study]9.6157892
GSM549107patient 135, normal, homogenized [OPG study]9.791993
GSM549115patient 068, normal, homogenized [OPG study]10.522495
GSM549116patient 072, normal, homogenized [OPG study]10.064194
GSM549120patient 078, normal, homogenized [OPG study]10.204495
GSM549131patient 030, cancer, homogenized [OPG study]9.1806189
GSM549118patient 074, normal, homogenized [OPG study]9.9286993
GSM549129patient 027, cancer, homogenized [OPG study]9.0903790
GSM549123patient 088, normal, homogenized [OPG study]10.140594
GSM549124patient 006, cancer, homogenized [OPG study]9.1524491
GSM549126patient 015, cancer, homogenized [OPG study]9.4471892
GSM549128patient 025, cancer, homogenized [OPG study]9.4912492
GSM549103patient 117, normal, homogenized [OPG study]10.309295
GSM549117patient 073, normal, homogenized [OPG study]10.427995
GSM549138patient 041, cancer, homogenized [OPG study]9.9927294
GSM549141patient 045, cancer, homogenized [OPG study]10.007794
GSM549130patient 028, cancer, homogenized [OPG study]9.6725493
GSM549101patient 111, normal, homogenized [OPG study]9.6451593
GSM549105patient 128, normal, homogenized [OPG study]10.116395
GSM549106patient 134, normal, homogenized [OPG study]9.2008689
GSM549112patient 048, normal, homogenized [OPG study]10.353595
GSM549125patient 011, cancer, homogenized [OPG study]9.5058392
GSM549127patient 024, cancer, homogenized [OPG study]8.6437587
GSM549135patient 035, cancer, homogenized [OPG study]8.7461686